Foody JM, Ferdinand FD, Galusha D, Rathore SS, Masoudi FA, Havranek EP, Nilasena D, Radford MJ, Krumholz HM. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation. 2003;108(suppl 1):II24 II28. 192. Holman WL, Sansom M, Kiefe CI, Peterson ED, Hubbard SG, Delong JF, Allman RM. Alabama Coronary Artery Bypass Grafting Project: results from phase II of a statewide quality improvement initiative. Ann Surg. 2004;239:99 109. doi: 10.1097/01.sla.0000103065.17661.8f. 193. Williams JB, Delong ER, Peterson ED, Dokholyan RS, Ou FS, Ferguson TB Jr; Society of Thoracic Surgeons and the National Cardiac Database. Secondary prevention after coronary artery bypass graft surgery: find- ings of a national randomized controlled trial and sustained society-led incorporation into practice. Circulation. 2011;123:39 45. doi: 10.1161/ CIRCULATIONAHA.110.981068. 194. Yam FK, Akers WS, Ferraris VA, Smith K, Ramaiah C, Camp P, Flynn JD. Interventions to improve guideline compliance following coronary artery bypass grafting. Surgery. 2006;140:541 547. doi: 10.1016/j. surg.2006.05.014. 195. Hiratzka LF, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED; Get With the Guidelines Steering Committee. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter interven- tion and nonintervention patients in the Get With the Guidelines database. Circulation. 2007;116(suppl):I207 I212. doi: 10.1161/ CIRCULATIONAHA.106.681247. 196. Sj land H, Caidahl K, Lurje L, Hjalmarson A, Herlitz J. Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia. Br Heart J. 1995;74:235 241. 197. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting: the MACB Study Group. Eur Heart J. 1995;16:1825 1832. 198. 